疟疾抗体和流行性:它是否会影响SARS-CoV-2的严重程度和结果?
Prayas Sethi1, Tamoghna Ghosh1, Souradeep Chowdhury2
1Medicine, All India Institute of Medical Sciences, New Delhi, IND.
Cureus
|November 13, 2023
概括
这项研究调查了抗疟疾抗体是否影响了印度的2019年冠状病毒病 (COVID-19) 严重程度. 虽然抗体水平与疾病严重程度相关,但它们无法预测患者的生存结果.
科学领域:
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
- 流行病学 流行病学
背景情况:
- 与全球平均水平相比,印度的严重冠状病毒疾病2019 (COVID-19) 和死亡率较低.
- 一个假设表明,像印度这样的疟疾流行地区可能会对严重的COVID-19结果提供一些保护.
- 这项研究探讨了抗疟疾抗体在这种观察到的现象中的潜在作用.
研究的目的:
- 调查抗疟疾抗体水平与COVID-19的严重程度之间的关联.
- 为了确定抗疟疾抗体水平是否与COVID-19患者的结果相关,包括死亡率.
主要方法:
- 从2020年8月到2021年7月进行了一项横截面,分析和观察性研究.
- 数据来自印度新德里一家三级护理COVID-19中心的146名患者.
- 测量了抗疟疾抗体水平,并与疾病严重程度 (轻度,中度,严重) 和存活率相关联.
主要成果:
- 在患有轻度疾病与中度或重度疾病的患者之间观察到抗疟疾抗体水平的统计学上显著差异.
- 具体来说,在轻度和中度 (p=0.018),轻度和重度 (p=0.016),以及轻度和中度/重度组合 (p=0.013) 之间发现了显著的差异.
- 在存活的患者和没有存活住院的患者之间,没有发现抗疟疾抗体水平的显著差异.
结论:
- 抗疟疾抗体水平可能与2019年冠状病毒疾病的严重程度有关.
- 然而,抗疟疾抗体水平似乎与COVID-19患者在住院期间的结果无关.
- 需要进一步的研究,以了解抗疟疾抗体,COVID-19严重程度和患者预后之间的复杂关系.
相关概念视频
Cross-reactivity
Overview
Infectious Diseases and Their Occurrence
Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Yellow Fever
Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Coronavirus
Coronaviruses, including the severe acute respiratory syndrome coronavirus (SARS-CoV), are enveloped viruses characterized by their single-stranded, positive-sense RNA genome and helical nucleocapsid structure. The hallmark of these viruses is their club-shaped spike (S) glycoproteins that protrude from the viral envelope, facilitating attachment to host cells. Typically, coronaviruses infect the upper respiratory tract, often causing mild or asymptomatic disease. However, certain strains like...
Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...


